Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
VRTXEV to Sales History
Below historical average, structural decline.
Left:
|||
Enterprise value to sales ratio
Latest
9.15
↓ 25% below average
Average (9y)
12.22
Historical baseline
Range
High:29.46
Low:6.70
CAGR
-12.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 9.15 | -5.2% |
| 2023 | 9.66 | +34.0% |
| 2022 | 7.21 | +7.5% |
| 2021 | 6.70 | -26.2% |
| 2020 | 9.08 | -29.7% |
| 2019 | 12.92 | -1.8% |
| 2018 | 13.15 | -9.7% |
| 2017 | 14.56 | +40.8% |
| 2016 | 10.34 | -64.9% |
| 2015 | 29.46 | - |